Sector
Geography
Stage
Investment Year
Website
Healthcare
USA/China
Pre-IPO
2021
www.oncxerna.com
OncXerna Therapeutics
OncXerna is an advancing precision medicine company, which is transforming precision medicine beyond single genetic mutations by discovering the dominant biology of a person’s cancer at the RNA level through its Xerna RNA-based biomarker platform to advance more meaningful treatments for more cancer patients. The main medicine Bavituximab and Navicixizumab has been proved to be very efficient in the clinical trials.
The company is led by a team with deep discovery and clinical development expertise in the field of oncology. The company is a globalized company has offices in Waltham, Massachusetts and Shanghai, China.